European monoclonal antibodies market is estimated to grow at a CAGR of 7.2% during the forecast period. The increasing prevalence of cancer and rising approvals for monoclonal antibodies are some pivotal factors encouraging market growth. As per the World Health Organization (WHO), in Europe, there were nearly 4.2 million new cancer incidences reported in 2018. The most common forms of cancer reported in the region include breast cancer (12.4%), colorectum (11.8%), lung (11.1%), prostate (10.6%), bladder (4.7%), and other cancers (49.4%). Monoclonal antibodies act as one of the potentially used immune system proteins produced in the lab, which is highly useful in cancer treatment. These antibodies are developed naturally by the body and support the immune system to detect germs that cause disease, including viruses and bacteria, and point them for destruction. Monoclonal antibodies detect specific targets and thereby work to destroy cancer cells.

Request a free sample of our report on European Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/european-monoclonal-antibodies-market

European monoclonal antibodies market is segmented based on source and application. Based on the source, the market is classified into murine, chimeric, human, and humanized. Humanized monoclonal antibodies are expected to have potential application as it has major benefits compared to original mouse monoclonal antibodies. The monoclonal antibodies immunogenicity is reduced and the serum half-life of the monoclonal antibodies in humans is significantly enhanced. It is an established technique to reduce the immunogenicity of monoclonal antibodies from xenogeneic sources (usually rodent). In addition, it is used to improve the activation of the human immune system. Based on the application, the market is classified into cancer, infectious diseases, auto-immune diseases, inflammatory diseases, and others.

A full report of European Monoclonal Antibodies Market Is available at https://www.omrglobal.com/industry-reports/european-monoclonal-antibodies-market

Market Segmentation

European Monoclonal Antibodies Market

By Source

Murine

Chimeric

Human

Humanized

By Application

Cancer

Infectious Diseases

Auto-Immune Diseases

Inflammatory Diseases

Others

Regional Analysis

UK

Germany

France

Spain

Italy

Rest of European

Company Profiles

AstraZeneca plc

Bayer AG

Bristol-Myers Squibb Co.

F. Hoffmann-La Roche AG

Genmab A/S

GlaxoSmithKline plc

Innate Pharma S.A.

Mylan N.V.

Novartis AG

Pfizer Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-monoclonal-antibodies-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404